As of 2025-09-18, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (78.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.45 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -450.1%.
The range of the Relative Valuation is (66.98) - (81.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | (66.98) - (81.25) | (78.61) |
| Upside | -398.4% - -461.9% | -450.1% |
| Date | P/E |
| 2025-09-17 | -5.85 |
| 2025-09-16 | -5.81 |
| 2025-09-15 | -5.40 |
| 2025-09-12 | -5.23 |
| 2025-09-11 | -5.47 |
| 2025-09-10 | -5.05 |
| 2025-09-09 | -5.17 |
| 2025-09-08 | -5.06 |
| 2025-09-05 | -5.30 |
| 2025-09-04 | -4.71 |
| 2025-09-03 | -4.76 |
| 2025-09-02 | -4.14 |
| 2025-08-29 | -4.15 |
| 2025-08-28 | -4.28 |
| 2025-08-27 | -4.28 |
| 2025-08-26 | -4.22 |
| 2025-08-25 | -4.17 |
| 2025-08-22 | -4.22 |
| 2025-08-21 | -4.06 |
| 2025-08-20 | -4.08 |
| 2025-08-19 | -4.15 |
| 2025-08-18 | -4.34 |
| 2025-08-15 | -4.52 |
| 2025-08-14 | -4.47 |
| 2025-08-13 | -4.45 |
| 2025-08-12 | -4.28 |
| 2025-08-11 | -4.36 |
| 2025-08-08 | -4.47 |
| 2025-08-07 | -4.53 |
| 2025-08-06 | -4.64 |
| 2025-08-05 | -4.75 |
| 2025-08-04 | -4.85 |
| 2025-08-01 | -4.78 |
| 2025-07-31 | -5.00 |
| 2025-07-30 | -5.11 |
| 2025-07-29 | -5.06 |
| 2025-07-28 | -5.29 |
| 2025-07-25 | -5.51 |
| 2025-07-24 | -5.32 |
| 2025-07-23 | -5.62 |
| 2025-07-22 | -5.47 |
| 2025-07-21 | -5.34 |
| 2025-07-18 | -5.27 |
| 2025-07-17 | -5.19 |
| 2025-07-16 | -5.09 |
| 2025-07-15 | -4.97 |
| 2025-07-14 | -5.37 |
| 2025-07-11 | -5.37 |
| 2025-07-10 | -5.59 |
| 2025-07-09 | -5.45 |